0001250853-18-000121.txt : 20180906 0001250853-18-000121.hdr.sgml : 20180906 20180906200712 ACCESSION NUMBER: 0001250853-18-000121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180904 FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chin Richard CENTRAL INDEX KEY: 0001337252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36225 FILM NUMBER: 181058732 MAIL ADDRESS: STREET 1: C/O OXIGENE, INC. STREET 2: 230 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kindred Biosciences, Inc. CENTRAL INDEX KEY: 0001561743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461160142 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-701-7901 MAIL ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-09-04 0 0001561743 Kindred Biosciences, Inc. KIN 0001337252 Chin Richard C/O KINDRED BIOSCIENCES, INC. 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGGAME CA 94010 1 1 1 0 PRESIDENT AND CEO COMMON STOCK 2018-09-04 4 S 0 32400 14.81 D 2073671 D COMMON STOCK 2018-09-05 4 S 0 7600 14.69 D 2066071 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2017. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.75 to $14.95, inclusive. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.55 to $14.80, inclusive. /S/ Dietrick L. Miller, Attorney-in-Fact 2018-09-06